健康元
(600380)
| 流通市值：224.84亿 | | | 总市值：224.84亿 |
| 流通股本：18.29亿 | | | 总股本：18.29亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 7,898,328,250.41 | 4,089,279,479.56 | 15,619,480,306.89 | 11,898,828,905.02 |
| 营业收入 | 7,898,328,250.41 | 4,089,279,479.56 | 15,619,480,306.89 | 11,898,828,905.02 |
| 二、营业总成本 | 5,912,767,808.69 | 2,993,038,861.04 | 11,986,201,698.24 | 9,121,682,123.61 |
| 营业成本 | 2,985,132,575.95 | 1,558,416,030.26 | 5,827,852,690.99 | 4,393,919,087.41 |
| 税金及附加 | 99,500,263.72 | 48,498,322.81 | 190,409,297.76 | 137,567,242.03 |
| 销售费用 | 2,016,794,488.84 | 950,570,599.38 | 3,922,967,960.4 | 2,951,059,287.9 |
| 管理费用 | 421,890,723.11 | 220,886,435.03 | 911,595,557.28 | 708,729,617.84 |
| 研发费用 | 611,153,068.61 | 300,357,357.53 | 1,435,351,627.65 | 1,036,376,310.06 |
| 财务费用 | -221,703,311.54 | -85,689,883.97 | -301,975,435.84 | -105,969,421.63 |
| 其中:利息费用 | 45,725,827.28 | 22,898,186.53 | 123,261,483.95 | 94,972,898.62 |
| 其中:利息收入 | 246,070,795.96 | 110,971,266.84 | 417,296,591.13 | 245,985,558.7 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -6,699,818.51 | 1,709,488.73 | -17,495,836.34 | -5,736,443.62 |
| 加:投资收益 | 39,541,912.86 | 16,135,173.1 | 64,371,470.73 | 51,650,239.89 |
| 资产处置收益 | -149,723.72 | -86,129.77 | 45,262,713.71 | -370,399.04 |
| 资产减值损失(新) | -14,814,061.48 | -6,355,971.69 | -293,144,305.71 | -113,694,072.7 |
| 信用减值损失(新) | -7,332,423.75 | -8,180,086.41 | -7,262,094.01 | -797,210.83 |
| 其他收益 | 85,396,777.46 | 52,547,543.01 | 191,273,169.08 | 124,184,202.58 |
| 四、营业利润 | 2,081,503,104.58 | 1,152,010,635.49 | 3,616,283,726.11 | 2,832,383,097.69 |
| 加:营业外收入 | 5,194,263.72 | 1,173,822.28 | 7,784,838.89 | 6,920,279.4 |
| 减:营业外支出 | 13,955,342.84 | 2,065,905.08 | 49,181,919.67 | 19,988,508.91 |
| 五、利润总额 | 2,072,742,025.46 | 1,151,118,552.69 | 3,574,886,645.33 | 2,819,314,868.18 |
| 减:所得税费用 | 309,027,226.55 | 189,994,779.68 | 592,140,657.73 | 385,618,343.11 |
| 六、净利润 | 1,763,714,798.91 | 961,123,773.01 | 2,982,745,987.6 | 2,433,696,525.07 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 1,763,714,798.91 | 961,123,773.01 | 2,982,745,987.6 | 2,433,696,525.07 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 784,939,913.34 | 435,788,328.07 | 1,386,570,192.56 | 1,111,560,063.92 |
| 少数股东损益 | 978,774,885.57 | 525,335,444.94 | 1,596,175,795.04 | 1,322,136,461.15 |
| 扣除非经常损益后的净利润 | 769,813,117.3 | 423,759,792.88 | 1,319,327,822.48 | 1,073,381,416.07 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.43 | 0.23 | 0.74 | 0.59 |
| (二)稀释每股收益 | 0.43 | 0.23 | 0.74 | 0.59 |
| 八、其他综合收益 | -80,044,653.36 | -17,888,787.66 | -8,587,237.01 | -86,688,069.37 |
| 归属于母公司股东的其他综合收益 | -48,523,609.49 | -10,275,802.84 | -10,153,358.01 | -59,369,859.17 |
| 九、综合收益总额 | 1,683,670,145.55 | 943,234,985.35 | 2,974,158,750.59 | 2,347,008,455.7 |
| 归属于母公司股东的综合收益总额 | 736,416,303.85 | 425,512,525.23 | 1,376,416,834.55 | 1,052,190,204.75 |
| 归属于少数股东的综合收益总额 | 947,253,841.7 | 517,722,460.12 | 1,597,741,916.04 | 1,294,818,250.95 |
| 公告日期 | 2025-08-23 | 2025-04-25 | 2025-04-08 | 2024-10-25 |
| 审计意见(境内) | | | 标准无保留意见 | |